Current Report Filing (8-k)
August 25 2016 - 2:41PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) off
The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
August 23, 2016
NEUROMAMA, LTD.
(Exact name of registrant as specified
in charter)
Nevada
|
333-180750
|
98-0706304
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
Blvd. Benito Juarez Km 25.500,
Quinta Del Mar, Int. Suite 28
Playas de Rosarito B.C,
Mexico
|
c.p. 22710
|
(Address of principal executive offices)
|
(Zip Code)
|
+52 (664) 290-5048
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item
7.01 Regulation FD Disclosure
The
information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.
Attached
hereto as Exhibit 99.1 and incorporated by reference herein is a press release of Neuromama, Ltd. (the “Company”)
titled “Vladislav Zubkis aka. Steven Schwartzbard Takes Leave Of Absence From Embattled NeuroMama, Ltd.”
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
|
Exhibit Number
|
|
|
Description of Exhibit
|
|
99.1
|
|
|
Neuromama, Ltd. Press Release dated August 23, 2016
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
NEUROMAMA,
LTD.
|
|
|
|
|
|
Date:
August 24, 2016
|
By:
|
/s/ Igor
Weselovsky
|
|
|
|
Igor
Weselovsky, President, Chief Executive Officer & Director
|
|